Skip to main content
. 2022 Jul 13;13:918335. doi: 10.3389/fphar.2022.918335

FIGURE 1.

FIGURE 1

QSYQ post-treatment inhibited myocardial fiber rupture and cardiac fibrosis. (A) Effects of QSYQ post-treatment on the ultrastructure of myocardial tissues of rats in the Sham4W (a1), Sham10W (a2), Sham10W + TMZ (a3), Sham10W + QSYQ (a4), AAS4W (a5), AAS10W (a6), AAS10W + TMZ (a7), and AAS10W + TMZ (a8) groups. Scale bar = 1 μm. (B) Representative images of Masson’s trichrome staining in the Sham4W (b1 and c1), Sham10W (b2 and c2), Sham10W + TMZ (b3 and c3), Sham10W + QSYQ (b4 and c4), AAS4W (b5 and c5), AAS10W (b6 and c6), AAS10W + TMZ (b7 and c7), and AAS10W + TMZ (b8 and c8) groups. Scale bar = 200 μm. (C,D) Quantification results of interstitial fibrosis and perivascular fibrosis measured by Masson’s trichrome staining. Data are presented as the mean ± SEM, n = 3. * p < 0.05 vs. sham; # p < 0.05 vs. AAS. AAS, ascending aortic stenosis; C: cardiac myofibril; M: mitochondrial.